drugset / Trial / NCT04788641

Study to Assess the Effect of Sodium Zirconium Cyclosilicate on the Pharmacokinetics of Tacrolimus and Cyclosporin in Healthy Subjects

NCT04788641

Phase 1 Completed 62 enrolled AstraZeneca Parexel · collab
RandomizedCrossoverOpen-labelTreatment

Summary

This study will be an open-label, randomised sequence, 2-period, 2-cohort, 2-treatment in each cohort, cross-over study in healthy subjects (males and females of non-childbearing potential), performed at a single study centre.

Timeline

Start
2021-03-30
Primary completion
2021-09-16
Completion
2021-09-16

Drugs

EvaluationDrugModalityDoseRoute
Subject Cyclosporine Peptide Oral
Subject Sodium Zirconium Cyclosilicate Other / unclassified Oral
Subject Tacrolimus Small molecule Oral

Indications

No indication recorded.